TrialThe Journal of clinical investigation2017

A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations.

Rodrigo Hoyos-Bachiloglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.